Literature DB >> 19109767

Alterations in oxidative markers in the cerebellum and peripheral organs in MPS I mice.

Gustavo Kellermann Reolon1, Adalisa Reinke, Marcos Roberto de Oliveira, Luisa Macedo Braga, Melissa Camassola, Michael Everton Andrades, José Cláudio Fonseca Moreira, Nance Beyer Nardi, Rafael Roesler, Felipe Dal-Pizzol.   

Abstract

Mucopolysaccharidosis type I is a lysosomal storage disease with alterations in several organs. Little is known about the pathways that lead to the pathology. Evidences point oxidative stress on lysosomal storage diseases and mucopolysaccharidosis type I. The aim of the present study was to evaluate oxidative biomarkers on mucopolysaccharidosis type I mice model. We evaluated antioxidant enzymatic activity, protein damage and lipid peroxidation in the forebrain, cerebellum, heart, lung, diaphragm, liver, kidney and spleen. Superoxide dismutase activity was increased on cerebellum, lung, diaphragm, liver and kidney of mucopolysaccharidosis type I mice. Catalase activity was increased on cerebellum, spleen and lung. There was no alteration on glutathione peroxidase activity on any of the analyzed organs. Mucopolysaccharidosis type I mice showed increased carbonyl groups on cerebellum, heart and spleen. There was a decrease of thiobarbituric acid-reactive substances on the cerebellum of mucopolysaccharidosis type I mice. The results indicate a oxidative imbalance in this model. As lysosomes are very susceptible to oxidative damage, leading inclusive to cellular death, and lysosomal storage diseases present several alterations on this organelles, this finding can help to elucidate the cellular damage pathways on mucopolysaccharidosis type I.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109767     DOI: 10.1007/s10571-008-9335-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  21 in total

Review 1.  The cell biology of lysosomal storage disorders.

Authors:  Anthony H Futerman; Gerrit van Meer
Journal:  Nat Rev Mol Cell Biol       Date:  2004-07       Impact factor: 94.444

2.  Determination of carbonyl content in oxidatively modified proteins.

Authors:  R L Levine; D Garland; C N Oliver; A Amici; I Climent; A G Lenz; B W Ahn; S Shaltiel; E R Stadtman
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Neurodegeneration in the Niemann-Pick C mouse: glial involvement.

Authors:  D C German; C-L Liang; T Song; U Yazdani; C Xie; J M Dietschy
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

4.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

5.  NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.

Authors:  Mylvaganam Jeyakumar; David A Smith; Ian M Williams; Mario Cortina Borja; David C A Neville; Terry D Butters; Raymond A Dwek; Frances M Platt
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

6.  Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C.

Authors:  Eric C Bascuñan-Castillo; Robert P Erickson; Christy M Howison; Robert J Hunter; Randall H Heidenreich; Chad Hicks; Theodore P Trouard; Robert J Gillies
Journal:  J Appl Genet       Date:  2004       Impact factor: 3.240

7.  Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB.

Authors:  Guglielmo R D Villani; Nadia Gargiulo; Raffaella Faraonio; Sigismondo Castaldo; Enrico Gonzalez Y Reyero; Paola Di Natale
Journal:  J Neurosci Res       Date:  2007-02-15       Impact factor: 4.164

8.  Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy.

Authors:  Vanessa Gonçalves Pereira; Ana Maria Martins; Cecília Micheletti; Vânia D'Almeida
Journal:  Clin Chim Acta       Date:  2007-09-19       Impact factor: 3.786

9.  Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants.

Authors:  A Klegeris; P L McGeer
Journal:  J Neuroimmunol       Date:  1994-08       Impact factor: 3.478

10.  Long-term memory for aversive training is impaired in Idua(-/-) mice, a genetic model of mucopolysaccharidosis type I.

Authors:  Gustavo Kellermann Reolon; Luisa Macedo Braga; Melissa Camassola; Tatiana Luft; João Antônio Pêgas Henriques; Nance Beyer Nardi; Rafael Roesler
Journal:  Brain Res       Date:  2006-02-13       Impact factor: 3.252

View more
  15 in total

Review 1.  Common and uncommon pathogenic cascades in lysosomal storage diseases.

Authors:  Einat B Vitner; Frances M Platt; Anthony H Futerman
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

Review 2.  Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity.

Authors:  Louise D Archer; Kia J Langford-Smith; Brian W Bigger; James E Fildes
Journal:  J Inherit Metab Dis       Date:  2013-05-08       Impact factor: 4.982

3.  Proteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional polyacrylamide gel electrophoresis.

Authors:  Li Ou; Michael J Przybilla; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2016-10-11       Impact factor: 4.797

4.  Lipofuscin accumulation and gene expression in different tissues of mnd mice.

Authors:  Giovanna Traina; Paolo Bigini; Giuseppe Federighi; Leopoldo Sitia; Gabriela Paroni; Fabio Fiordaliso; Monica Salio; Caterina Bendotti; Marcello Brunelli
Journal:  Mol Neurobiol       Date:  2012-03-08       Impact factor: 5.590

Review 5.  Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms.

Authors:  Derbis Campos; Madelyn Monaga
Journal:  Metab Brain Dis       Date:  2012-04-14       Impact factor: 3.584

6.  Retroviral-vector-mediated gene therapy to mucopolysaccharidosis I mice improves sensorimotor impairments and other behavioral deficits.

Authors:  Guilherme Baldo; David F Wozniak; Kevin K Ohlemiller; Yanming Zhang; Roberto Giugliani; Katherine P Ponder
Journal:  J Inherit Metab Dis       Date:  2012-09-15       Impact factor: 4.982

7.  Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice.

Authors:  Guilherme Baldo; Fabiana Quoos Mayer; Barbara Martinelli; Anna Dilda; Fabiola Meyer; Katherine P Ponder; Roberto Giugliani; Ursula Matte
Journal:  Behav Brain Res       Date:  2012-05-09       Impact factor: 3.332

8.  Unfolded protein response is not activated in the mucopolysaccharidoses but protein disulfide isomerase 5 is deregulated.

Authors:  Guglielmo R D Villani; Armando Chierchia; Daniele Di Napoli; Paola Di Natale
Journal:  J Inherit Metab Dis       Date:  2011-10-15       Impact factor: 4.982

9.  Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II.

Authors:  Hélène F E Gleitz; Claire O'Leary; Rebecca J Holley; Brian W Bigger
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

10.  Apoptosis status and proliferative activity in mucopolysaccharidosis type I mice tongue mucosa cells.

Authors:  Juliana Noguti; Vanessa Gonçalves Pereira; Joice Marques Guilheiro; Ana Maria Martins; Vânia D'Almeida; Daniel Araki Ribeiro
Journal:  Dent Res J (Isfahan)       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.